… pneumonia and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia
with long-term inhaled corticosteroid use … trials of any inhaled corticosteroid vs a control …

… an increased risk of pneumonia associated with prolonged use of inhaled corticosteroids
(ICS… However, as yet, no statistically significant increase in pneumonia-related 30-day mortality …

Background In clinical trials, the use of inhaled corticosteroids is associated with an increased
risk of pneumonia in people with COPD, but whether the same is true for people with …

… to the relationship between pneumonia risk and ICS utilization (I 2 = 39.6%, p = 0.043). With
the fixed-effects model, we observed clear increases in pneumonia risk as ICS use rose [RR …

… The use of inhaled corticosteroids has been associated with an increased … study do not
support any increased risk of pneumonia in patients with asthma using inhaled corticosteroids. …

… of inhaled corticosteroids (ICS) in COPD may be associated with an increased risk of
pneumonia. … by use of oral and inhaled corticosteroids, those with current use of inhaled and oral …

… Use of inhaled anticholinergics is a risk factor for pneumonia in asthmatics 18 ; … on
pneumonia risk cannot be ruled out and could confound an assertion of increased pneumonia risk …

… Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in …
It is unclear whether the risk of pneumonia varies for different inhaled agents, particularly …

… The use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease
(COPD) has been associated with an increased risk of pneumonia in controlled clinical trials …

… A meta-analysis was implemented to evaluate whether exposure to inhaled corticosteroids
was associated with risk of pneumonia. We used Review Manager 5.3 software (v.5.3, …